Primerica, Inc. filings document operating results and governance matters for a financial services company built around term life insurance and investment and savings product distribution. Recent 8-K reports furnish quarterly results and non-GAAP measures such as adjusted operating revenues, adjusted operating income, adjusted net operating income, diluted adjusted operating earnings per share, and adjusted stockholders’ equity, including treatment of IPO coinsurance transactions and investment gains or losses.
Proxy and governance filings cover director elections, executive compensation, pay-versus-performance data, board matters, and stockholder voting procedures. Other current reports document bylaw provisions for stockholder-requested special meetings and board composition disclosures.
Primerica, Inc. updated its corporate bylaws to formalize when shareholders can demand a special meeting. Under the new Fourth Amended and Restated By-Laws, the board must call a special meeting if one or more shareholders request it and collectively hold at least a majority of the company’s voting power for at least twelve months before the request.
The bylaws add detailed information and documentation requirements for any special meeting request and specify several circumstances when the board is not required to call such a meeting, including timing near an annual meeting, repeat or substantially similar business, or noncompliance with legal and bylaw standards.
Primerica, Inc. chief executive officer and director Glenn J. Williams reported an open-market sale of company stock. On February 17, 2026, he sold 2,500 shares of Primerica common stock at a price of $256.4111 per share. Following this transaction, Williams directly beneficially owned 27,391.995 shares of Primerica common stock.
A person associated with Primerica, Inc. filed a Form 144 notice to sell 2,500 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The shares have an aggregate market value of $627,225.00 based on the figures in the notice.
The securities were originally acquired as restricted stock awards from the issuer on 03/01/2025, with the same date listed for acquisition and payment. The notice also states that the filer does not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
Primerica, Inc. reported strong fourth quarter and full-year 2025 results, driven by record Investment and Savings Products (ISP) performance and solid term life insurance earnings. Fourth quarter total revenues reached $853.7 million, up 8% from a year earlier. Net income was $197.0 million, an 18% increase, with diluted EPS of $6.13 versus $4.98 from continuing operations in the prior-year quarter. Adjusted operating revenues were $853.5 million, up 8%, while adjusted net operating income rose 16% to $196.9 million and diluted adjusted operating EPS grew 22% to $6.13.
For full-year 2025, net income was $751.2 million, up 4% versus net income from continuing operations in 2024, and diluted EPS increased 9% to $22.91. Adjusted net operating income grew 10% to $751.4 million, and diluted adjusted operating EPS rose 16% to $22.92. Record ISP product sales of $4.1 billion in the quarter were up 24%, and average ISP client asset values increased 14% to $128.2 billion, ending the year at $129 billion. The Term Life segment delivered 2% growth in direct premiums and 5% growth in pre-tax operating income.
Return on stockholders’ equity was 33.2%, and adjusted net operating income return on adjusted stockholders’ equity was 33.5% in the quarter. Primerica returned significant capital to stockholders, completing a $450 million share repurchase authorization in 2025, with the Board approving a new $475 million repurchase program through December 31, 2026. The Board also approved a 15% increase in the quarterly dividend to $1.20 per share, payable March 13, 2026. Primerica Life Insurance Company’s estimated statutory RBC ratio was 455% as of December 31, 2025.
Primerica, Inc. reported that two long-serving board members, Beatriz R. Perez and Gary L. Crittenden, have informed the Board that they will not stand for reelection at the annual meeting of stockholders to be held in May 2026. Ms. Perez has served on the Board for over 11 years and Mr. Crittenden for over 12 years. The company states that each director’s decision is not related to any differences or disagreements with the company, the Board, management, or its operations, policies, or practices. Primerica expresses gratitude for their many years of service and contributions.
Primerica director reports reinvestment of phantom stock dividends. On 12/15/2025, the director acquired 54.139 shares reported as common stock at $258.08 per share through dividends paid on phantom stock that were reinvested in additional phantom stock under the Non-Employee Directors' Deferred Compensation Plan.
After this transaction, the director beneficially owned 19,150.7123 shares in total, held directly. The phantom stock is convertible into common stock on a one-for-one basis according to the plan terms.
Primerica, Inc. reported that one of its directors acquired 36.71 shares of phantom stock on 12/15/2025 at $258.08 per share. The acquisition resulted from dividends on existing phantom stock that were reinvested automatically into additional phantom stock under the Non-Employee Directors' Deferred Compensation Plan.
After this transaction, the director beneficially owned 28,279.7277 shares held directly. The phantom stock is convertible into common stock on a one-for-one basis in accordance with the terms of the plan.
Primerica reported an insider transaction by a director involving phantom stock under the Non-Employee Directors' Deferred Compensation Plan. On 12/15/2025, the director acquired 45.385 additional shares of phantom stock at $258.08 per share, representing dividends that were automatically reinvested. After this transaction, the director beneficially owns 11,307.7937 shares of phantom stock, which are convertible into common stock on a one-for-one basis under the plan.
A director of Primerica, Inc. reported reinvestment of dividends into 78.43 shares of phantom stock on 12/15/2025 at $258.08 per share under the Non-Employee Directors' Deferred Compensation Plan. After this transaction, the director beneficially owns 19,541.171 shares of phantom stock on a direct basis. Phantom stock under this plan is convertible into common stock on a one-for-one basis.
Primerica, Inc. reported a small equity-related transaction by one of its directors. On 12/15/2025, the director was credited with 83.116 shares tied to Primerica common stock at a price of $258.08 per share. This was not an open-market trade, but the automatic reinvestment of dividends on existing phantom stock into additional phantom stock units under the company’s Non-Employee Directors' Deferred Compensation Plan.
Following this transaction, the director beneficially owned 20,708.701 shares of Primerica common stock on a direct basis. Under the plan, phantom stock is convertible into Primerica common stock on a one-for-one basis in accordance with the plan’s terms, so these deferred compensation units track the company’s share price and further align the director’s interests with shareholders.